Crossmark

Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients

Crossref DOI link: https://doi.org/10.1007/s00432-020-03488-0

Published Online: 2021-04-02

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Jinfeng

Hao, Jian

Niu, Yangyang

Wu, Xiongzhi https://orcid.org/0000-0001-8277-5667
Funding

Funding for this research was provided by:

The National Science Foundation of China (81903934)
License Information

Text and Data Mining valid from 2021-04-02

Version of Record valid from 2021-04-02
More Information

Article History

Received: 17 July 2020

Accepted: 30 November 2020

First Online: 2 April 2021

Compliance with ethical standards

:

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below